Amicus Therapeutics, Inc. - FOLD Quarterly Revenue Growth

Amicus Therapeutics (FOLD) - corporate logo

Amicus Therapeutics (FOLD) possesses exceptional pricing power due to its monopoly in the treatment of rare pathologies. The magnitude of quarterly revenue growth visualizes this status, where 23.90 reflects the latest value of the metric. Revenues are based on the protected status of Galafold, which generates high margins. However, gene therapy behemoths create risks as they compete for a limited patient pool.

FOLD Amicus Pharma Quarterly Sales Growth Rate (07/04/2022 - 05/09/2026)

Summary analytical data breakdowns for Amicus Therapeutics Inc (FOLD)

- current quotes and average value forecast:
Initial company analysis:amicusrx.com (FOLD)
Manufactured products of Amicus Therapeutics, Inc.

For Amicus Therapeutics (FOLD), which possesses pricing power in the orphan drug niche, the quarterly revenue growth rate serves as an indicator of operational efficiency and market penetration. This metric measures sales dynamics on a daily basis, allowing for the real-time assessment of the business's reaction to macroeconomic shifts, which helps investors distinguish sustainable profit growth from random short-term fluctuations.

Competitors of Amicus Therapeutics

ASND - Revenue Growth QoQ|MDGL: Revenue Growth QoQ|CORT: Quarterly Revenue Growth|RYTM - Quarterly Sales Growth Rate|Revenue Growth QoQ Akero Corp|Metsera Therapeutics (MTSR) - Quarterly Sales Growth Rate|Revenue Growth QoQ moonlaketx.com (MLTX)|Quarterly Sales Growth Crinetics Pharmaceuticals CRNX|Revenue Growth QoQ NewAmsterdam Pharma N.V. NAMS|Quarterly Sales Growth Rate Soleno Therapeutics Inc (SLNO)|89bio Corp - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Revenue Growth QoQ|Quarterly Sales Growth MiMedx Group, Inc.|Revenue Growth QoQ Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth MBX|Quarterly Sales Growth Altimmune, Inc. ALT|Quarterly Revenue Growth AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Quarterly Revenue Growth Rate|BIOA: Quarterly Sales Growth|Quarterly Revenue Increase BMEA (Biomea Fusion)|QNCX (quincetx.com) - Quarterly Sales Growth|Fractyl - Quarterly Revenue Increase|VTVT (vTv Therapeutics Inc) - Quarterly Revenue Growth|Agape ATP - Revenue Dynamics QoQ|Quarterly Sales Growth PLUR (Pluri Inc)|Quarterly Sales Growth Rate Synlogic Inc.|Revenue Growth QoQ Lipocine Inc. LPCN|Matinas BioPharma (MTNB) - Quarterly Revenue Growth Rate|Spruce Biosciences Inc. - Quarterly Revenue Growth|Quarterly Sales Growth Rate Galecto, Inc. GLTO|Carmell Therapeutics (CTCX) - Revenue Growth QoQ|Lumos Pharma - Quarterly Revenue Increase|ONVO (Organovo Corp) - Quarterly Revenue Growth|Radius Pharmaceuticals (RDUS) - Quarterly Sales Growth Rate